Prophylactic anticoagulants for people hospitalised with COVID-19-Reference-Cited by-同舟云学术

Prophylactic anticoagulants for people hospitalised with COVID-19

Published:2020-10-02 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Flumignan Ronald LG¹,Tinôco Jéssica Dantas de Sá²,Pascoal Patricia IF¹,Areias Libnah L¹,Cossi Marcelly S²,Fernandes Maria ICD²,Costa Isabelle KF³,Souza Larissa⁴,Matar Charbel F⁵,Tendal Britta⁶,Trevisani Virginia FM⁷,Atallah Álvaro N⁸,Nakano Luis CU¹

Affiliation:

1. Department of Surgery, Division of Vascular and Endovascular Surgery; Universidade Federal de São Paulo; São Paulo Brazil

2. Department of Nursing; State University of Rio Grande do Norte; Natal Brazil

3. Department of Nursing; Federal University of Rio Grande do Norte; Natal Brazil

4. Department of Public Health; State University of Rio Grande do Norte; Natal Brazil

5. Department of Internal Medicine; American University of Beirut Medical Center; Beirut Lebanon

6. Living Guidelines Program, Cochrane Australia; Melbourne Australia

7. Medicina de Urgência and Rheumatology; Escola Paulista de Medicina, Universidade Federal de São Paulo and Universidade de Santo Amaro; São Paulo Brazil

8. Cochrane Brazil; Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde; São Paulo Brazil

Publisher

Wiley

Subject

Pharmacology (medical)

Reference96 articles.

1. The association between treatment with heparin and survival in patients with Covid-19;Ayerbe;Journal of Thrombosis and Thrombolysis,2020

2. The association between treatment with heparin and survival in patients with Covid-19;Ayerbe;medRxiv

3. Liu X Zhang X Xiao Y Gao T Wang G Wang Z Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment medRxiv [Preprint] 10.1101/2020.04.23.20076851

4. Paranjpe I Fuster V Lala A Russak AJ Glicksberg BS Levin MA Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19 Journal of the American College of Cardiology 2020 76 1 122 4 32387623

5. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study;Russo;Pharmacological Research,2020

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased 90-Day Morbidity and Mortality Among Patients With Hip Fracture During the COVID-19 Pandemic;Orthopedics;2024-09-04

2. The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials;International Journal of Cardiology;2023-07

3. Factors of venous thromboembolism among COVID-19 patients;Asian Journal of Pharmaceutical Research and Health Care;2023

4. Vascular complications in 305 severely ill patients with COVID-19: a cohort study;Sao Paulo Medical Journal;2023

5. A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients;The Anatolian Journal of Cardiology;2023